DE3855801D1 - Anwendungsgebiete von beta-adrenergenen Agonisten - Google Patents

Anwendungsgebiete von beta-adrenergenen Agonisten

Info

Publication number
DE3855801D1
DE3855801D1 DE3855801T DE3855801T DE3855801D1 DE 3855801 D1 DE3855801 D1 DE 3855801D1 DE 3855801 T DE3855801 T DE 3855801T DE 3855801 T DE3855801 T DE 3855801T DE 3855801 D1 DE3855801 D1 DE 3855801D1
Authority
DE
Germany
Prior art keywords
beta
effects
adrenergic
reversing
adrenergic agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3855801T
Other languages
English (en)
Other versions
DE3855801T2 (de
Inventor
Charlotte Anne Maltin
Peter John Reeds
Margret Inkster Delday
Susan Mary Hay
Frazer George Smith
Gerald Edward Lobley
Patricia Margret Dorward
Robert Michael Palmer
Kenneth Charles Mchardy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rowett Research Institute
Original Assignee
Rowett Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721602A external-priority patent/GB8721602D0/en
Priority claimed from GB888803619A external-priority patent/GB8803619D0/en
Application filed by Rowett Research Institute filed Critical Rowett Research Institute
Application granted granted Critical
Publication of DE3855801D1 publication Critical patent/DE3855801D1/de
Publication of DE3855801T2 publication Critical patent/DE3855801T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3855801T 1987-09-15 1988-09-12 Anwendungsgebiete von beta-adrenergenen Agonisten Expired - Lifetime DE3855801T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878721602A GB8721602D0 (en) 1987-09-15 1987-09-15 Therapeutic applications of beta-adrenergic agonists
GB888803619A GB8803619D0 (en) 1988-02-17 1988-02-17 Therapeutic applications of beta-adrenergic agonists

Publications (2)

Publication Number Publication Date
DE3855801D1 true DE3855801D1 (de) 1997-04-03
DE3855801T2 DE3855801T2 (de) 1997-07-03

Family

ID=26292734

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3855801T Expired - Lifetime DE3855801T2 (de) 1987-09-15 1988-09-12 Anwendungsgebiete von beta-adrenergenen Agonisten

Country Status (4)

Country Link
EP (2) EP0662324A1 (de)
AT (1) ATE149089T1 (de)
DE (1) DE3855801T2 (de)
ES (1) ES2100148T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203040B (en) * 1988-07-05 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing weight-increasing composition containing 1-(3,5-dihydroxy-phenyl)-2-(terc-butyl-amino)-ethanol
US5281623A (en) * 1990-08-27 1994-01-25 Eli Lilly And Company Method for treating inflammation
EP0488435A1 (de) * 1990-11-26 1992-06-03 Duphar International Research B.V Verfahren zur Steigerung des Muskel/Fett-Verhältnisses bei landwirtschaftlichen Nutztieren
US6524532B1 (en) 1995-06-20 2003-02-25 The Regents Of The University Of California Microfabricated sleeve devices for chemical reactions
US6015837A (en) * 1996-08-29 2000-01-18 New York Medical College Method for treating scoliosis with β2-adrenoceptor agonists
CA2455248A1 (en) * 2004-01-29 2005-07-29 Alexander Zolotoy Oral administration of r-albuterol against obesity
MX2008007790A (es) 2005-12-22 2009-03-04 Anaborex Inc Composiciones y metodos para la prevencion y tratamiento de caquexia.
GB0625270D0 (en) * 2006-12-19 2007-01-31 Univ Leicester Angiogenesis
JP5627452B2 (ja) 2007-04-24 2014-11-19 アカシア ファーマ リミテッドＡｃａｃｉａ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ 筋肉減少の治療に使用される薬剤の組合せ
PL220308B1 (pl) 2011-06-03 2015-10-30 Kobel Buys Krystyna Zastosowanie klenbuterolu do leczenia objawów autyzmu dziecięcego oraz klenbuterol do zastosowania w leczeniu objawów autyzmu dziecięcego
JO3192B1 (ar) * 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60530A (en) * 1979-08-16 1984-10-31 American Cyanamid Co Animal feed compositions useful as growth promotors and for reduction of fat in animals,comprising phenylethanolamine derivatives and certain such novel compounds
GR79758B (de) * 1983-01-31 1984-10-31 Lilly Co Eli
GB8806471D0 (en) * 1988-03-18 1988-04-20 Tisdale M J Biologically active material characterised by catabolic activity generally associated with cachexia inducing tumours

Also Published As

Publication number Publication date
EP0308157A3 (de) 1992-01-15
ES2100148T3 (es) 1997-06-16
EP0662324A1 (de) 1995-07-12
DE3855801T2 (de) 1997-07-03
EP0308157B1 (de) 1997-02-26
ATE149089T1 (de) 1997-03-15
EP0308157A2 (de) 1989-03-22

Similar Documents

Publication Publication Date Title
ATE149089T1 (de) Anwendungsgebiete von beta-adrenergenen agonisten
DE69636278D1 (de) Inhibitor des muskelproteinabbaus enthaltend einen il-6 rezeptor antikörper
FR2496458B1 (fr) Composition huileuse destinee au traitement des matieres keratiniques et de la peau
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
EP0401903A3 (de) Verwendung von Vanilloiden zur Behandlung von Erkrankungen der Atemwege
DE69022953D1 (de) Zusammensetzungen zur Behandlung von Fettablagerungen.
IL68350A (en) N-glycosylated carboxamide derivatives,their preparation and their use for the treatment of animals
ZA898605B (en) Compositions for topical treatment of skin diseases
FR2510889B1 (fr) Medicament contenant certains phosphates ribofurannosyl-3',5'-cycliques substitues en 6, 8 pour le traitement de maladies proliferatives de la peau
EP0417003A3 (en) Use of antiprogestomimetics for stimulating ovulation
DE3889974D1 (de) Pyrazol-Derivate und diese enthaltende Behandlungsmittel für cerebrovaskulare Krankheiten.
ATE59780T1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
ATE14982T1 (de) Zusammensetzungen mit gehalt an paromomycin zur oertlichen behandlung der leishmaniasis der haut.
ZA822158B (de)
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
ES2019713A6 (es) Un procedimiento para preparar derivados clorados de adenosina.
FR2600531B1 (fr) Appareil pour le traitement d'etats pathologiques par stimulation de points d'acupuncture.
DE3374066D1 (en) N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor
DE69011272D1 (de) 3-Substituierte-2-Oxindolderivate als Interleukin-Biosynthesehemmer.
DE69118847D1 (de) Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus
SU1797195A1 (ru) Способ профилактики радиационных поражений
AU1775088A (en) Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type
BE885851A (fr) Composition therapeutique pour le traitement de la dustrophie musculaire, de la myopathie et de la myotonie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition